Increased PUFA Content and 5-Lipoxygenase Pathway Expression Are Associated with Subcutaneous Adipose Tissue Inflammation in Obese Women with Type 2 Diabetes.

Mattijs M Heemskerk, Martin Giera, Fatiha El Bouazzaoui, Mirjam A Lips, Hanno Pijl, Ko Willems van Dijk, Vanessa van Harmelen

Journal: Nutrients 2016;7(9):7676-90

PMID: 26378572

Abstract

Obese women with type 2 diabetes mellitus (T2DM) have more inflammation in their subcutaneous white adipose tissue (sWAT) than age-and-BMI similar obese women with normal glucose tolerance (NGT). We aimed to investigate whether WAT fatty acids and/or oxylipins are associated with the enhanced inflammatory state in WAT of the T2DM women. Fatty acid profiles were measured in both subcutaneous and visceral adipose tissue (vWAT) of 19 obese women with NGT and 16 age-and-BMI similar women with T2DM. Oxylipin levels were measured in sWAT of all women. Arachidonic acid (AA) and docosahexaenoic acid (DHA) percentages were higher in sWAT, but not vWAT of the T2DM women, and AA correlated positively to the gene expression of macrophage marker CD68. We found tendencies for higher oxylipin concentrations of the 5-LOX leukotrienes in sWAT of T2DM women. Gene expression of the 5-LOX leukotriene biosynthesis pathway was significantly higher in sWAT of T2DM women. In conclusion, AA and DHA content were higher in sWAT of T2DM women and AA correlated to the increased inflammatory state in sWAT. Increased AA content was accompanied by an upregulation of the 5-LOX pathway and seems to have led to an increase in the conversion of AA into proinflammatory leukotrienes in sWAT.

Address: Department of Human Genetics, Leiden University Medical Center, Leiden 2300 RC, The Netherlands. [email protected].; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden 2300 RC, The Netherlands. [email protected].; Center of Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2300 RC, The Netherlands. [email protected].; Department of Human Genetics, Leiden University Medical Center, Leiden 2300 RC, The Netherlands. [email protected].; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden 2300 RC, The Netherlands. [email protected].; Department of Medicine, division Endocrinology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands. [email protected].; Department of Medicine, division Endocrinology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands. [email protected].; Department of Human Genetics, Leiden University Medical Center, Leiden 2300 RC, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden 2300 RC, The Netherlands.; Department of Medicine, division Endocrinology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden 2300 RC, The Netherlands. [email protected].; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden 2300 RC, The Netherlands. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.